Business Context and Reporting Period
Creative Medical Technology Holdings, Inc., a Nevada corporation and emerging growth company, filed this Form 8-K on August 10, 2018, reporting events occurring on August 8, 2018. The filing details a short-term financing arrangement entered into to secure immediate liquidity.
Key Financial Metrics
- Debt Issuance: The Company issued a Promissory Note with a principal amount of $107,000.
- Cash Proceeds: The Company received $106,500 in net proceeds from the transaction.
- Interest Rate: The Note accrues compound interest monthly at an annual rate of 8%.
- Maturity Date: The debt matures on August 22, 2018 (14-day term).
- Security Status: The Note is unsecured and non-convertible into equity.
Material Changes and Terms
The filing discloses a new liability not present in prior periods. Key terms include a "most favored nation" provision and a specific repayment trigger: if the Company completes a capital raise of at least $100,000, it must pay the Lender 25% of the gross proceeds within one business day to reduce the Note balance. Additionally, default provisions exist that would increase the interest rate to 24% if triggered.
Outlook, Risks, and Contingencies
The Company faces a significant liquidity risk due to the extremely short maturity date of the Note (August 22, 2018). The repayment structure creates a contingency where future fundraising efforts could be immediately encumbered by a 25% gross proceeds payment requirement. The risk of default is elevated by the short duration and the potential for a punitive interest rate increase to 24% upon default.
Investor Verification Checklist
- Verify the Company's ability to repay the $107,000 principal plus accrued interest by the August 22, 2018 maturity date.
- Confirm whether the Company has initiated or plans to initiate a capital raise of $100,000 or more, which would trigger an immediate 25% gross proceeds payment.
- Review the full text of the Securities Purchase Agreement (Exhibit 99.1) for additional covenants or restrictions not summarized in the 8-K.
- Assess the Company's current cash position to determine if the $106,500 proceeds were sufficient to meet immediate operational needs or if they were used to refinance existing obligations.